BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 34938318)

  • 1. Intra-Tumoral Expression of SLC7A11 Is Associated with Immune Microenvironment, Drug Resistance, and Prognosis in Cancers: A Pan-Cancer Analysis.
    He J; Ding H; Li H; Pan Z; Chen Q
    Front Genet; 2021; 12():770857. PubMed ID: 34938318
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pan-Cancer Analyses Confirmed the Ferroptosis-Related Gene
    Lin Y; Dong Y; Liu W; Fan X; Sun Y
    Int J Gen Med; 2022; 15():2501-2513. PubMed ID: 35282646
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MiR-27a-3p Promotes Non-Small Cell Lung Cancer Through SLC7A11-Mediated-Ferroptosis.
    Lu X; Kang N; Ling X; Pan M; Du W; Gao S
    Front Oncol; 2021; 11():759346. PubMed ID: 34722314
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The roles of ferroptosis regulatory gene SLC7A11 in renal cell carcinoma: A multi-omics study.
    Xu F; Guan Y; Xue L; Zhang P; Li M; Gao M; Chong T
    Cancer Med; 2021 Dec; 10(24):9078-9096. PubMed ID: 34761566
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ferroptosis regulator SLC7A11 is a prognostic marker and correlated with PD-L1 and immune cell infiltration in liver hepatocellular carcinoma.
    Liang Y; Su S; Lun Z; Zhong Z; Yu W; He G; Wang Q; Wang J; Huang S
    Front Mol Biosci; 2022; 9():1012505. PubMed ID: 36267158
    [No Abstract]   [Full Text] [Related]  

  • 6. Pan-Cancer Analysis of PARP1 Alterations as Biomarkers in the Prediction of Immunotherapeutic Effects and the Association of Its Expression Levels and Immunotherapy Signatures.
    Zhang X; Wang Y; A G; Qu C; Chen J
    Front Immunol; 2021; 12():721030. PubMed ID: 34531868
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic and Immunological Role of Key Genes of Ferroptosis in Pan-Cancer.
    Shi ZZ; Tao H; Fan ZW; Song SJ; Bai J
    Front Cell Dev Biol; 2021; 9():748925. PubMed ID: 34722530
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IMCA Induces Ferroptosis Mediated by SLC7A11 through the AMPK/mTOR Pathway in Colorectal Cancer.
    Zhang L; Liu W; Liu F; Wang Q; Song M; Yu Q; Tang K; Teng T; Wu D; Wang X; Han W; Li Y
    Oxid Med Cell Longev; 2020; 2020():1675613. PubMed ID: 32322334
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SLC7A11 Reduces Laser-Induced Choroidal Neovascularization by Inhibiting RPE Ferroptosis and VEGF Production.
    Zhao X; Gao M; Liang J; Chen Y; Wang Y; Wang Y; Xiao Y; Zhao Z; Wan X; Jiang M; Luo X; Wang F; Sun X
    Front Cell Dev Biol; 2021; 9():639851. PubMed ID: 33681224
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Deubiquitylase OTUB1 Mediates Ferroptosis via Stabilization of SLC7A11.
    Liu T; Jiang L; Tavana O; Gu W
    Cancer Res; 2019 Apr; 79(8):1913-1924. PubMed ID: 30709928
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Solute Carrier Family 7 Member 11 (SLC7A11) is a Potential Prognostic Biomarker in Uterine Corpus Endometrial Carcinoma.
    Fang X; Zhang T; Chen Z
    Int J Gen Med; 2023; 16():481-497. PubMed ID: 36777097
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The amino acid transporter SLC7A11-mediated crosstalk implicated in cancer therapy and the tumor microenvironment.
    He J; Wang X; Chen K; Zhang M; Wang J
    Biochem Pharmacol; 2022 Nov; 205():115241. PubMed ID: 36084707
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterizing the role of SLC3A2 in the molecular landscape and immune microenvironment across human tumors.
    He J; Liu D; Liu M; Tang R; Zhang D
    Front Mol Biosci; 2022; 9():961410. PubMed ID: 35992269
    [No Abstract]   [Full Text] [Related]  

  • 14. AhR Promotes the Development of Non-small cell lung cancer by Inducing SLC7A11-dependent Antioxidant Function.
    Peng Y; Ouyang L; Zhou Y; Lai W; Chen Y; Wang Z; Yan B; Zhang Z; Zhou Y; Peng X; Chen J; Peng X; Xiao D; Liu S; Tao Y; Liu W
    J Cancer; 2023; 14(5):821-834. PubMed ID: 37056388
    [No Abstract]   [Full Text] [Related]  

  • 15. RNA binding protein NKAP protects glioblastoma cells from ferroptosis by promoting SLC7A11 mRNA splicing in an m
    Sun S; Gao T; Pang B; Su X; Guo C; Zhang R; Pang Q
    Cell Death Dis; 2022 Jan; 13(1):73. PubMed ID: 35064112
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Role of Cystine/Glutamate Antiporter SLC7A11/xCT in the Pathophysiology of Cancer.
    Jyotsana N; Ta KT; DelGiorno KE
    Front Oncol; 2022; 12():858462. PubMed ID: 35280777
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protein tyrosine phosphatase 1 protects human pancreatic cancer from erastin-induced ferroptosis.
    Huang XD; Xiao FJ; Guo YT; Sun Y; Zhang YK; Shi XJ
    Asian J Surg; 2022 Nov; 45(11):2214-2223. PubMed ID: 35000852
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SLC7A11, a Potential Therapeutic Target Through Induced Ferroptosis in Colon Adenocarcinoma.
    Cheng X; Wang Y; Liu L; Lv C; Liu C; Xu J
    Front Mol Biosci; 2022; 9():889688. PubMed ID: 35517862
    [No Abstract]   [Full Text] [Related]  

  • 19. Long Noncoding RNA LINC00578 Inhibits Ferroptosis in Pancreatic Cancer via Regulating SLC7A11 Ubiquitination.
    Li H; Wei Y; Wang J; Yao J; Zhang C; Yu C; Tang Y; Zhu D; Yang J; Zhou J
    Oxid Med Cell Longev; 2023; 2023():1744102. PubMed ID: 36846713
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pan-Cancer Analysis Reveals Disulfidoptosis-Associated Genes as Promising Immunotherapeutic Targets: Insights Gained from Bulk Omics and Single-Cell Sequencing Validation.
    Xu B; Li M; Weng N; Zhou C; Chen Y; Wei J; Fu L
    Biomedicines; 2024 Jan; 12(2):. PubMed ID: 38397869
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.